Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Hims & Hers Health Inc. buy Canaccord Genuity Group Inc.

Start price
€13.60
10.04.24 / 50%
Target price
€18.55
10.04.25
Performance (%)
-13.93%
Price
€11.71
29.04.24
Summary
This prediction is currently active. The price of Hims & Hers Health Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -13.93%. This prediction currently runs until 10.04.25. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this prediction
Performance without dividends (%)
Name 1w
Hims & Hers Health Inc. 4.978%
iShares Core DAX® 0.961%
iShares Nasdaq 100 2.626%
iShares Nikkei 225® 0.217%
iShares S&P 500 1.540%

Comments by Canaccord_Genuity_Gr for this prediction

In the thread Hims & Hers Health Inc. diskutieren
Prediction Buy
Perf. (%) -13.93%
Target price 18.548
Change
Ends at 10.04.25

Hims & Hers Health, Inc. (NYSE: HIMS) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $20.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat